Afghanistan Afghan Public Health Institute Strategic Plan - ianphi

Develop a pharmaceutical (including pharmaceuticals manufacturing) regulatory implementationplan initially focusing on those gaps that are identified as prioritiesEstablish a sustainable mechanism for post‐marketing surveillance on medicinesImplement a revised regulatory framework policy and effective enforcement methodologyStrategic Objective‐3 (SO‐3): To establish and implement a system of good governance to ensuretransparency and efficiency in supply chain management and commodity security of pharmaceuticalsincluding vaccinesPriority Interventions:Use and expand the existing Coordinated Procurement and Distribution System (CPDS) forcoordination, oversight, procurement, quantification, delivery/distribution etc. of allpharmaceuticals in the public health sectorEnhance the capacity of the Pharmaceuticals Donations Office (PDO) to act as a regulatory andcoordinating body of the GD Pharmaceutical Affairs (GDPA), for all medicine donations to thecountryEstablish and implement systems of good pharmaceutical practice to ensure transparency andefficiency in supply chain management and commodity securityDevelop standardized plans, mechanisms, Standard Operating Procedures (SOPs), and tools toimplement an Management Information System for data and information sharing and reporting onall pharmaceuticals by all active partiesEstablish coordination of the vaccine supply to ensure reliable availabilityEstablish biomedical/technical equipment coordination mechanismStrategic Objective‐4 (SO‐4): To build sustainable capacity for effective essential medicinesmanagementPriority Interventions:Develop and implement a human resource, education and training strategy to address thedeficiencies in current pharmaceutical capacities and provide a degree of sustainability throughcontinuous capacity/professional developmentFacilitate the provision of technical assistance to all the schools of pharmacy for the incorporation ofmodern pharmaceutical management concepts in their curriculaDevelop a new National Medicine PolicyDevelop a pharmaceutical waste management programUpgrade the Central Warehouse operationsStrategic Objective‐5 (SO‐5): To advocate for and support increased local pharmaceutical productioncapacityPriority Interventions:Ministry of Public Health Strategic Plan, 2011‐201548